-
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart FailureDM Cibi, KW Bi-Lin, MK Singh et al. -
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility ModulationAbraham WT, Kuck KH, FIX-HF-5 Investigators and Coordinators.
-
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusFarmakis D, Agostoni P, Baholli L et al.
-
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJanuzzi JL Jr, Richards AM.
-
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-ReducedF Zannad, JP Ferreira, SJ Pocock et al.
-
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionSD Solomon, the PARAGON-HF Investigators and Committees. JohnJV McMurray,
-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNational Institue for Health and Care Excellence
-
Longitudinal Change in Galectin-3 and Incident Cardiovascular OutcomesA Ghorbani, V Bhambhani, RH Christenson et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
